Recent Finacing
Recent Raise
Eribis Pharmaceuticals develops a cardio-protective drug candidate for acute myocardial ischemia, targeting acute coronary syndrome, reperfusion injury and surgical preconditioning, advancing from preclinical studies toward clinical trials.
Focus Areas
Recent Investors
Funding round
Investor